AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02687789 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Medical Device: Vagisan® Lactic Acid
Description: application of Vagisan® Lactic Acid: 2 days per week (with a treatment-free interval of three days or two days, respectively; e.g. Monday and Friday)
Study NCT04281524 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CSL312
Description: CSL312 administered as an IV infusion
Study NCT03436836 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lidocaine, bupivacaine , hyaluronidase
Description: 2% lidocaine, 4 ml of 0.5% bupivacaine with hyaluronidase (75IU)
Study NCT01570920 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: physical training
Description: walking many times a week
Study NCT01848197 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: paclitaxel
Study NCT01848197 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: paclitaxel
Study NCT05533723 — intervention group
Intervention type: PROCEDURE
Intervention: Endoscopic epidural neuroplasty
Description: EEN catheter, iDolphine S2 (Meta Biomed Co., Ltd, Osong, Korea) was placed in the epidural space through sacral hiatus. EEN was done on the target segments.~During EEN, normal saline was infused into epidural space under epiduroscopic vision. Dexamethasone (5 mg), 0.3% mepivacaine 10 mL, and hyaluronidase (3000 IU) were injected through catheter at the target segments. Holmium-Yag laser was used to cut epidural fibrous bands and for coagulation of epidural bleeding.
Study NCT05533723 — intervention group
Intervention type: PROCEDURE
Intervention: Percutaneous epidural neuroplasty (PEN)
Description: PEN catheter, EDEN-CC (JMT, Yangju, Korea) was placed in the epidural space and neural foramen . PEN was done on the target segments. Dexamethasone (5 mg), 0.3% mepivacaine 10 ml, and hyaluronidase (3000 IU) were injected through the PEN catheter.
Study NCT04281524 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Solution of 70% 0.9% saline / 30% CSL312 diluent
Study NCT04117945 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: Given IV
Study NCT04117945 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan
Description: Given IV
Study NCT04117945 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Panitumumab
Description: Given IV
Study NCT04117945 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Regorafenib
Description: Given PO
Study NCT06359340 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Psychosocial treatment
Description: Participants randomly assigned to one of four psychosocial treatment conditions including cognitive behavioral therapy and a certified recovery specialist.
Study NCT03928236 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Limited Intraoperative Benzodiazepine
Description: policy for limited use of intraoperative benzodiazepine
Study NCT03928236 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Liberal Intraoperative Benzodiazepine
Description: policy for liberal use of intraoperative benzodiazepine
Study NCT03865225 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Biofeedback
Description: 9 x 10 minutes biofeedback sessions over period of three days
Study NCT03865225 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham-Biofeedback
Description: 9 x 10 minutes sham-biofeedback sessions over period of three days
Study NCT00458159 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CC-11006
Description: Doses: 10mg, 15mg, 25mg, 35mg, \& 50mg, taken once daily, orally.
Study NCT03853096 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cefazolin
Description: Cefazolin 100mg/mL, 3mL in three locations will be administered around a surgical incision on the anterior shoulder in a standard deltopectoral approach interval. This will be a one time administration. Administration and route will be subcutaneous.
Study NCT01917084 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Passive range of motion (ROM) exercise
Description: After their Norwood surgery, stable subjects will undergo passive ROM exercise therapy for up to 21 consecutive days or until hospital discharge, whichever comes first. Subjects will have completed the study after their anthropometric measurements are collected at 3 months of age
Study NCT01226524 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bu Zhong Yi Qi Tang, Zhi Xue Tang, Chuan xin lian kang yan pian mod, Tian Wang Bu xin Dan
Description: A traditional Chinese Medicine (TCM) therapist will diagnose and prescribe the herbal remedies according to TCM principles from one of four formulations or any combination of the four formulation
Study NCT03417739 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BVD-523
Description: ERK1 and ERK2 inhibitor
Study NCT02928458 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Omnipaque
Study NCT02928458 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: MD-Gastroview
Study NCT04162197 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GEO
Description: Robot-Assisted Gait Training (RAGT) The Robotic Group (RG) performs a Robot-Assisted Gait Training (RAGT) using an end-effector robotic device (G-EO system-Reha Technology-Olten, Switzerland).
Study NCT04162197 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GEO and HUNOVA
Description: Robot-Assisted Gait Training (RAGT) and Balance Training. The Balance Group (GHG) performs a Robot-Assisted Gait Training (RAGT) using an end-effector robotic device (G-EO system-Reha Technology-Olten, Switzerland) and a Balance training using a robotic proprioceptive platform (Hunova - Movendo Technology, Italy).
Study NCT04315272 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Azithromycin
Description: Zithromax® for oral suspension is supplied in bottles containing azithromycin dehydrate powder equivalent to 1200mg per bottle and the following inactive ingredients: sucrose; tribasic anhydrous sodium phosphate; hydroxypropyl cellulose; xanthan gum; FD\&C Red #40; and flavoring including spray dried artificial cherry, crème de vanilla, and banana. After constitution, a 5mL suspension contains 200mg of azithromycin.
Study NCT04315272 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT03004508 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Gingko Biloba Extract
Description: 120mg/day, twice a day, 6 month
Study NCT03004508 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 120mg/day, twice a day, 6 month
Study NCT05889039 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: BEMER
Description: Bio-Electro-Magnetic Energy Regulation (BEMER) is an emerging therapeutic modality that deploys a biorhythmically defined stimulus through a pulsed electromagnetic field and has been shown to reduce musculoskeletal pain.
Study NCT05889039 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BEMER
Description: Bio-Electro-Magnetic Energy Regulation (BEMER) is an emerging therapeutic modality that deploys a biorhythmically defined stimulus through a pulsed electromagnetic field and has been shown to reduce musculoskeletal pain.
Study NCT05889039 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: OMT
Description: Osteopathic manipulative therapy (OMT) is a form of manual therapy utilized by osteopathic physicians and some allopathic physicians to treat a broad variety of musculoskeletal ailments, including neck pain.
Study NCT05889039 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: OMT
Description: Osteopathic manipulative therapy (OMT) is a form of manual therapy utilized by osteopathic physicians and some allopathic physicians to treat a broad variety of musculoskeletal ailments, including neck pain.
Study NCT04088656 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Systems Analysis and Improvement Approach for Hypertension Screening and Treatment Optimization
Description: The Systems Analysis and Improvement Approach to Optimize the Hypertension Care Cascade for People Living with HIV (SAIA-HTN) is a five-step systems analysis and iterative improvement cycle intervention which will be implemented by study nurses and district managers in intervention facilities. Components of the intervention include joint care cascade analysis, patient flow mapping and continuous quality improvement, aimed to incrementally improve hypertension screening, diagnosis, treatment and care in the HIV+ population at intervention health facilities.
Study NCT02791399 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ISOP Intervention with the Nurse Care Manager
Description: A Nurse Care Manager (NCM) will maintain a registry of enrolled patients, track opioid medication-related events from the medical record, and provide decision support to Primary Care Providers for issues related to prescription opioid safety. The NCM will also meet individually with enrolled participants in the intervention group to discuss strategies for preventing/reducing opioid side effects, preventing diversion, and providing rationale for screening for prescription opioid misuse.
Study NCT02158260 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Position changing
Study NCT04407260 — intervention group
Intervention type: DEVICE
Intervention: Oxygen Hood
Description: High-Flow Oxygen Hood with neck dam and intake and exhaust tubing incorporating a Bacterial/Viral HEPA filter and optional PEEP attachment.
Study NCT01994590 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dovitinib
Description: Starting dose will be 400 mg by mouth daily on Days 1-5, 8-12, 15-19, and 22-26 of each 28 day cycle.
Study NCT01994590 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abiraterone Acetate
Description: 4 tablets (250 mg each) by mouth daily.
Study NCT01994590 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: 5 mg by mouth twice daily.
Study NCT04078178 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Niagen
Description: Nicotinamide Riboside
Study NCT04078178 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Placebo Comparator
Description: Placebo
Study NCT03376100 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound guided nerve blocks
Description: Ultrasound guided nerve blocks of the radial and median nerves
Study NCT03376100 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Hematoma Block
Description: Conventional local anesthetic method using hematoma block
Study NCT02394678 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AngioJet Thrombectomy System
Description: Mechanical removal of blood, using a pressurised jet of water, from ventricles of patients suffering from intraventricular haemorrhage
Study NCT00426231 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Navigation by a health worker
Description: Help provided by health worker to navigate medication access programs
Study NCT00426231 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Information control
Description: Information about medication access programs provided to the participant and their healthcare provider
Study NCT04259554 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: OFC rTMS
Description: repetitive transcranial magnetic stimulation over right orbito-frontal cortex with 1Hz (360 pulses in 6 trains á 60 pulses with 30s intertrain-interval)
Study NCT04177927 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Capnostream 20p / Coviden
Description: The special nasal canule is used for detection carbondioxide from breathe of patients
Study NCT04177927 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Rutine monitoring
Description: peripheric Oxygen saturation is monitored.
Study NCT03577470 — intervention group
Intervention type: DRUG
Intervention: D/C/F/TAF Fixed-Dose Combination (FDC)
Description: Participants in treatment with D/C/F/TAF FDC, coming from different treatment histories will be observed in this study. No interventions will be administered as a part of this study.
Study NCT06712381 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluorouracil
Description: Carac (fluorouracil) Cream, 0.5% is used by adults to treat skin conditions on the face and front part of the scalp called solar keratosis or actinic keratosis.
Study NCT06712381 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Photodynamic therapy
Description: Photodynamic therapy (PDT) is a procedure that uses a photosensitizing drug to apply light therapy selectively to target pre-skin cancer, acne and sun damage.
Study NCT06712381 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Carac in combination with PDT
Study NCT06711445 — intervention group
Intervention type: OTHER
Intervention: Tele-assessment
Description: The participants were evaluated in two settings on different days (24-48 h apart): (i) in clinical settings (face-to-face) and (ii) at home via 'WhatsApp' phone application (both asynchronized and synchronized tele-assessment).~The evaluations steps were as follows:~1. Face-to-face/ Clinic assessment: Rater 1 completed all clinical assessments.~2. Synchronized tele-assessment: Rater 1 repeated the same evaluations via video calls to the patients (these were recorded to be used in step 3).~3. Asynchronized tele-assessment: Rater 2 evaluated the recordings of the remote evaluations (made in step 2).~4. Retest of synchronized tele-assessment: Rater 1 evaluated patients via video calls (these were recorded to be used in step 5).~5. Retest of asynchronized tele-assessment: Rater 2 evaluated the recordings of the remote evaluations (made in step 4).
Study NCT05267977 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cephalosporin 1St Generation
Study NCT05267977 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aminoglycosides
Study NCT01590069 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Aerosolized Aldesleukin
Description: Breathe aerosolized aldesleukin
Study NCT01590069 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Optional correlative studies
Study NCT05889039 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham OMT + Sham BEMER
Description: Participants in the CONTROL group received light touch and BEMER sham treatments. Researchers placed their hands lightly on the subject's cervical paraspinal muscles in the supine position and on the upper thoracic paraspinal muscles in the prone position for approximately 5 minutes. This was done to mimic myofascial release techniques; however, no pressure or action was done. In addition, the subject's laid supine on the BEMER mat (as they would do during a BEMER session), but the device was not activated.
Study NCT00002727 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: radiation therapy
Study NCT00002727 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiation therapy
Study NCT00605150 — intervention group
Intervention type: RADIATION
Intervention: TheraSphere-Yttrium 90 microsphere
Description: TheraSphere is delivered to the liver via a catheter placed into the femoral artery and guided by fluoroscopy to the hepatic artery. Once the catheter is properly positioned, the physician infuses TheraSphere, which localizes preferentially in the tumor.
Study NCT03729557 — intervention group
Intervention type: PROCEDURE
Intervention: Nephrectomy
Description: Unilateral nephrectomy
Study NCT00006942 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bryostatin 1
Description: Given IV
Study NCT00006942 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cisplatin
Description: Given IV
Study NCT00006942 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT04513327 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Rehabilitation using Digital Healthcare System (Uincare Homeplus)
Description: Uincare Homeplus is a device using infrared, kinect camera and motion capture technology to track 3D motion of the patients' posture and joint articulations. It also has embedded exercise training software dedicated to anterior cruciate ligament reconstruction post-op rehabilitation at home.~Home-based self-rehabilitation using brochure for 2 weeks post surgery (same as the active comparator)~Home-based self-rehabilitation using digital healthcare system(Uincare Homeplus) for 2 to 12 weeks post surgery.
Study NCT04513327 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Rehabilitation
Description: Home-based self-rehabilitation using brochure for 12 weeks post surgery.
Study NCT03526562 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Exercise according to dose escalation
Study NCT03157349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biofreeze
Description: Biofreeze is a topical analgesic that uses the cooling effect of menthol, a natural pain reliever, to soothe minor muscle and joint pain. The product will be applied 10 minutes prior to manipulation and at home for 4 times a day for 1 week
Study NCT03157349 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Placebo
Description: The placebo is the Biofreeze product with all active ingredients removed. The product will be applied 10 minutes prior to manipulation and at home for 4 times a day for 1 week
Study NCT00571480 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: acupuncture
Description: ear acupuncture needles will be inserted into three preselected acupuncture points which are thought to be specific for low back pain
Study NCT00571480 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham acupuncture
Description: ear acupuncture needles are inserted into three preselected acupuncture points which are thought not specific to low back pain
Study NCT00571480 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: standard of care
Description: participants can take acetaminophen 650 mg no more than every 6 hours and frequent rest and topical warm/cold compress
Study NCT06401941 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hyperbaric Oxygen Therapy
Description: HBO session includes three 20-minute inhalations of pure oxygen in a hyperbaric chamber utilizing specially fitted face masks for each patient. The session is conducted as follows: 10 minutes compression of up to 2.5 atm (0.25 MPa), inhalation of 100% oxygen for 20 minutes, a 5-minute break in the chamber without the mask (oxygen concentration up to 23%, constant temperature (room) and humidity), again 20 minutes inhalation of 100% oxygen, another 5-minute break (the same condition), the last 20 minutes inhalation of 100% oxygen, and finally a 10-minute decompression. The total duration of the session was 90 minutes.
Study NCT02743221 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trifluridine/tipiracil + bevacizumab
Description: Patients were treated withTrifluridine/tipiracil + bevacizumab regimen until they met a discontinuation criterion.
Study NCT02743221 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Capecitabine + bevacizumab
Description: Patients were treated with capecitabine+ bevacizumab regimen until they met a discontinuation criterion.
Study NCT03228732 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Oral Tablet
Description: There will be two 2-day inpatient visits with 8-weeks of treatment with placebo between those visits.
Study NCT03228732 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluoxetine
Description: There will be two 2-day inpatient visits with 8-weeks of treatment with fluoxetine between those visits.
Study NCT03228732 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: DHEA
Description: There will be two 2-day inpatient visits with 8-weeks of treatment with DHEA between those visits.
Study NCT03228732 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluoxetine and DHEA
Description: There will be two 2-day inpatient visits with 8-weeks of treatment with fluoxetine and DHEA between those visits.
Study NCT01655680 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ABT-126
Description: ABT-126 Middle Dose
Study NCT01655680 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ABT-126
Description: ABT-126 Low Dose
Study NCT01655680 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ABT-126
Description: ABT-126 High Dose
Study NCT01655680 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT00053365 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: irofulven
Description: Given IV
Study NCT02831374 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Local anesthesia
Description: The surgical extraction under local anesthesia (2% Lignocaine and 1:100000 Adrenaline) procedure was the same in all patients.
Study NCT02831374 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Local anesthesia
Description: The surgical extraction under local anesthesia (2% Lignocaine and 1:100000 Adrenaline) procedure was the same in all patients.